%PDF-1.7
%
1 0 obj
<<
/Lang (EN)
/MarkInfo 2 0 R
/Metadata 3 0 R
/Names 4 0 R
/OpenAction [5 0 R /FitH 910]
/Outlines 6 0 R
/PageLabels 7 0 R
/PageLayout /SinglePage
/PageMode /UseOutlines
/Pages 8 0 R
/StructTreeRoot 9 0 R
/Threads [10 0 R]
/Type /Catalog
>>
endobj
11 0 obj
<<
/Author (Henrotin, Y., Marty, M., Mobasheri, A.)
/CreationDate (D:20140521000751Z)
/Creator (Elsevier)
/ElsevierWebPDFSpecifications (6.4)
/Keywords (Osteoarthritis; Chondroitin; glucosmaine)
/ModDate (D:20140521000819+05'30')
/Producer (Acrobat Distiller 9.0.0 \(Windows\))
/Subject (Chondroitin sulfate and glucosamine sulfate exert beneficial effects on the metabolism of in vitro models of cells derived from synovial joints: chondrocytes, synoviocytes and cells from subchondral bone, all of which are involved in osteoarthritis \(OA\). They increase type II collagen and proteoglycan synthesis in human articular chondrocytes and are able to reduce the production of some pro-inflammatory mediators and proteases, to reduce the cellular death process, and improve the anabolic/catabolic balance of the extracellular cartilage matrix \(ECM\). Clinical trials have reported a beneficial effect of chondroitin sulfate and glucosamine sulfate on pain and function. The structure-modifying effects of these compounds have been reported and analyzed in recent meta-analyses. The results for knee OA demonstrate a small but significant reduction in the rate of joint space narrowing. Chondroitin sulfate and glucosamine sulphate are recommended by several guidelines from international societies for the management of knee and hip OA, while others do not recommend these products or recommend only under condition. This comprehensive review clarifies the role of these compounds in the therapeutic arsenal for patients with knee OA)
/Title (What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?)
/Trapped /True
/doi (10.1016/j.maturitas.2014.04.015)
/robots (noindex)
/Journal (Maturitas)
>>
endobj
2 0 obj
<<
/Marked true
>>
endobj
3 0 obj
<<
/Length 12 0 R
/Subtype /XML
/Type /Metadata
>>
stream
application/pdf
10.1016/j.maturitas.2014.04.015
What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?
Yves Henrotin
Marc Marty
Ali Mobasheri
Chondroitin
Glucosamine
Osteoarthritis
Cartilage
Maturitas, Corrected proof. doi:10.1016/j.maturitas.2014.04.015
Elsevier Ireland Ltd
journal
Maturitas
© 2014 The Authors show Published by Elsevier Ireland Ltd. All rights reserved.
0378-5122
10.1016/j.maturitas.2014.04.015
http://dx.doi.org/10.1016/j.maturitas.2014.04.015
6.4
10.1016/j.maturitas.2014.04.015
noindex
Elsevier
2014-05-21T00:07:51Z
2014-05-21T00:08:19+05:30
True
True
Acrobat Distiller 9.0.0 (Windows)
uuid:68e2cafc-52f2-4329-93a9-5f234e2e9a7d
uuid:f03552fb-ac88-4fe6-a7b0-333fd32654b3
endstream
endobj
4 0 obj
<<
/Dests 13 0 R
>>
endobj
5 0 obj
<<
/Annots [14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R
24 0 R 25 0 R 26 0 R 27 0 R]
/B [28 0 R 29 0 R 30 0 R]
/BleedBox [33.4000015259 38 645.700012207 848.700012207]
/Contents [31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R]
/CropBox [41.9000015259 46.5 637.200012207 840.200012207]
/MediaBox [33.4000015259 38 645.700012207 848.700012207]
/Parent 8 0 R
/Resources 39 0 R
/Rotate 0
/StructParents 1
/Tabs /S
/TrimBox [41.9000015259 46.5 637.200012207 840.200012207]
/Type /Page
>>
endobj
6 0 obj
<<
/Count 14
/First 40 0 R
/Last 40 0 R
>>
endobj
7 0 obj
<<
/Nums [0 41 0 R]
>>
endobj
8 0 obj
<<
/Count 4
/Kids [5 0 R 42 0 R 43 0 R 44 0 R]
/Type /Pages
>>
endobj
9 0 obj
<<
/K [45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R
55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R
65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R]
/ParentTree 72 0 R
/ParentTreeNextKey 5
/Type /StructTreeRoot
>>
endobj
10 0 obj
<<
/F 28 0 R
/I 73 0 R
>>
endobj
12 0 obj
5582
endobj
13 0 obj
<<
/Kids [74 0 R]
>>
endobj
14 0 obj
<<
/A 75 0 R
/Border [0 0 0]
/F 4
/Rect [247.8179931641 59.5289993286 437.8729858398 65.8089981079]
/Subtype /Link
/Type /Annot
>>
endobj
15 0 obj
<<
/A 76 0 R
/Border [0 0 0]
/F 4
/Rect [299.2409973145 798.1129760742 391.0690002441 803.1370239258]
/Subtype /Link
/Type /Annot
>>
endobj
16 0 obj
<<
/A 77 0 R
/Border [0 0 0]
/F 4
/Rect [370.200012207 771.1140136719 421.4159851074 777.0120239258]
/Subtype /Link
/Type /Annot
>>
endobj
17 0 obj
<<
/A 78 0 R
/Border [0 0 0]
/F 4
/Rect [310.700012207 715.4229736328 475.4339904785 721.1779785156]
/Subtype /Link
/Type /Annot
>>
endobj
18 0 obj
<<
/Border [0 0 0]
/Dest (MAT6159AFF0005)
/F 4
/Rect [157.4329986572 627.1699829102 176.2519989014 634.0250244141]
/Subtype /Link
/Type /Annot
>>
endobj
19 0 obj
<<
/Border [0 0 0]
/Dest (MAT6159COR0005)
/F 4
/Rect [164.3520050049 627.1699829102 183.171005249 634.0250244141]
/Subtype /Link
/Type /Annot
>>
endobj
20 0 obj
<<
/Border [0 0 0]
/Dest (MAT6159AFF0010)
/F 4
/Rect [234.43800354 627.1699829102 253.2570037842 634.0250244141]
/Subtype /Link
/Type /Annot
>>
endobj
21 0 obj
<<
/Border [0 0 0]
/Dest (MAT6159AFF0015)
/F 4
/Rect [316.3370056152 627.1699829102 335.1570129395 634.0250244141]
/Subtype /Link
/Type /Annot
>>
endobj
22 0 obj
<<
/Border [0 0 0]
/Dest (MAT6159AFF0020)
/F 4
/Rect [322.9530029297 627.1699829102 341.7730102539 634.0250244141]
/Subtype /Link
/Type /Annot
>>
endobj
23 0 obj
<<
/Border [0 0 0]
/Dest (MAT6159AFF0025)
/F 4
/Rect [330.4639892578 627.1699829102 349.282989502 634.0250244141]
/Subtype /Link
/Type /Annot
>>
endobj
24 0 obj
<<
/A 79 0 R
/Border [0 0 0]
/F 4
/Rect [425.0239868164 370.782989502 601.1740112305 376.4349975586]
/Subtype /Link
/Type /Annot
>>
endobj
25 0 obj
<<
/A 80 0 R
/Border [0 0 0]
/F 4
/Rect [143.6770019531 132.9069976807 205.6020050049 137.9320068359]
/Subtype /Link
/Type /Annot
>>
endobj
26 0 obj
<<
/A 81 0 R
/Border [0 0 0]
/F 4
/Rect [84.6320037842 114.7529983521 236.6750030518 119.7770004272]
/Subtype /Link
/Type /Annot
>>
endobj
27 0 obj
<<
/A 82 0 R
/Border [0 0 0]
/F 4
/Rect [87.0859985352 97.6169967651 243.6640014648 102.6409988403]
/Subtype /Link
/Type /Annot
>>
endobj
28 0 obj
<<
/N 29 0 R
/P 5 0 R
/R [85 392 606 813]
/T 10 0 R
/V 83 0 R
>>
endobj
29 0 obj
<<
/N 30 0 R
/P 5 0 R
/R [85 195 606 346]
/T 10 0 R
/V 28 0 R
>>
endobj
30 0 obj
<<
/N 84 0 R
/P 5 0 R
/R [354 339 606 346]
/T 10 0 R
/V 29 0 R
>>
endobj
31 0 obj
<<
/Filter /FlateDecode
/Length 85 0 R
>>
stream
HW[oFb-Z$v]il(>0m)ĄgHВSB<<]w>F^ByOU9y7͊N7'R|"u)3T0GUxUh!V8.Ri9?eDj ?-~/ }t}Jcg|S2eo DE UW,pGϩFwސ@U綘^~rxqyT1&z̓ȹBh:!@sKb2]"be)7G|I,SE(nQ-"b%0jʍ#X'p+~,>&)1k `(7OX5*=URz6]ZjHV
$&)aB81u
ʤ59,o3 .%Mwa7/ǼLdH9U*
]X9VrIY$0ų'ɨrs*CJRqeT7m[Ң44ctew').0Az}sDRz6D9Uc[:Jh,43Ԝ(qY@X/\/ofS뤠eRB#mj$JCXθӰF5QtЁLaȌEk[meD{T{G^wAp1QTu㱿)dEͦXyg8JcvqQ 6eT2;Y&qד4?LiҤR;F8.y}|:ξYM{=!=]EXD15#/0v =Ty*5uƐeqqJm;Jcpďߋջz6ggMuLO9y~vZLwƑjC$M. ;Ť'm]\
AC\zwgn" np>ٛ'M._yyœ/yTj &bF
Kz1SCZfj?%9ofrnDsZΟ]?S%#.іxL1oMBC59&xHC4&Hrʋ0kN+Omc_D1G{)㫉ga!1wL|j\ǔo+_4*MN-~$k\X2h_*[XvAy~-LN1Ƕfc )D 41̃l֜>8,nZ(poANu}O[|1^8;K\l`Y9C8]\.eHqXOsc;MD +jf0
⽍@N.Dm]u{P^Y;T,ydB}*wuc&Z\ߴ5{WgCDT~k档CpjUL_89k7ac,"V Ho%4WJ!#,U0hr(D,xdFF++GSчINa"
èR. h^`'5oVI0{٬ϪDY8 Dj~6-U<cMxrS^-tTeWOW_QO>'TP3,KPx视UΏTS</4|w;eTjBC֍}?ۖ#oǝ&63͟| Ȕ&,d[1ʱm`.$5Pik Ĝ9D1J7O2?)u&,I\2T7m$aJGGkM&K|u[Cms8.d":ռYf-fTUz\}*]ls*&:!DJmcr=KaabQ_^/ofShf*4@ N8ֲ˳t)23sYÎ)Hrj|k[%j~1` 3gúNʒ@aauZ1(*nʶ
-6?n y{wR߿:m30pP{qpz6{aU0%¢pc<'>V>B4 nǐn_a1(8\&w7qG1'{{m֜:pdQLKKo"G$cz^*2v2S$TdE)8ϖ4(v3I%2#9oޕy!8M|Ԛqnjw?Px,1֏tf zTxKH@J
P/ӟ@9f`GaZah/iIsaD8xpݻӛ"v1NWeySCʠ5M¨.k3b_֫$u
.ێ`:w4%Q6DEoJ@5Y .R ~Y %T>vpFȥb$%a^x+3ERHGiv^[8p3-6c<-6/fSlD1GT9,Q&dAUvf"qJ3IbQYY_Sxӯw9U:aHb'qr M:~խn55d,CSw0ABb
(950#QI}du9{33]y_o)fsv$ܴfnd&ϫ1UY}O;mfڄIz*$&:m7&taɰ,W5^nlV,aGT>hx00 )1y~*{H+Ҿӡnw*yC^_$cEPDBf4,nFGuK iRt1'*'a 6W/ЭG?ùhݢ[NMQrϛvM$Xƣf|!C{QT_ymoxU>jI^pU߇ `gL2%/x20CsZꆙ2);tMk\7xgS1 ,ܑ+&2(,UtѮYזN6D@Qބ lvB%9=H9?:I9ymƞ(ߒţxy~XxtQ=v@,$%< E8PIU:, Y(,4ttl#(ī-K1&xFUJVA׃QlV[o9vϾ؍HJ[0mx|u/ŵݤ-ypv6ÂeKqM7w5Y8p9ZYW<$p
X2d !(B qV$H8Ӽ]?<#f @a^vXtք,,D+ֆB r8,uEXma3}.Q%R [E
!2I|YvJ/5A"*e<#A\~yyQl^nѬXv
#''C:@7MZCIukNzZqԡ^=QDL>FA
7 ;mNE|e%Pb<4ނ4څ88pҮqV@|sP~
߂1 'nU]#L(MBlsu3H.TQk<7*Bc1dt5rD7w,8TƊy^)emA)UCGlMs4D-lO۶]JrVtp.{ou+VsIUN9|qF[[M~YAW^`lR:
3oly4ct}\m9veߖJynvϢyS Ӷ"Xiz=?L r|B1yaIk`IEQygojծ<#@Ex(³7* HTYo3iHDZĂ<1 Nfb5bS!ź24Pik鳳?Tr X`>g:m21 &T!yܰxrBO//YBNYI`kmTwH.RGļ.ESC*-Q<źe!AJTQ~%^nW'w8dYy2F0?岹a
^k$")OPф<:6Q1OgT]r&f If%0
\6eBⰔοGrH0.
мBIߎѮeXvnh
zr9wxKLpNWRV~
mʧQdЏK@>(B|,qȋM8G9<_*$!$p2`4Xxx\|}p^~^M=+I*Ip@0۪/H.r(KYWTb&2TSa_5?,Ll;aŊdlo/T9A6c?k6=.*/ENJpƔEx".o^`V#q͊2`#0Uc%8,Na^%4~C!Uy١[4ݪyd2<
uEŮ6<26kUf+LO$wyo~g8oULnaS??_/IvWg4+_۾ƛ?<|{o0'uzdҫem#JIU<5摛>咣/LYLqEDoN)k!ċ&n\;LJ\]۩P1|Q.d>墂H0JXk}2+T/ TUcAHDF=0"Ğb)m!99;I3cce{",UJϏ㊷|{{U*vb?STnZ\5.ð,&|G)ZĀ!I0S8T,ǭPN,Mrs cb2#X0 eu`Hz$bogl=֍jyVg˔{ja\1jBo j{|(nITORbF" l)!wf]O*h+Q u.SZ?iy'ۢ&K:VmJDŽ̾ݼ %Y52kM